- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Buy the Dip
Hong Kong Pharmaceuticals & Biotech Buy the Dip
UPDATED Aug 11, 2022
Companies which may present a buying opportunity after a dip in share price.
11 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 1877Shanghai Junshi Biosciences | HK$31.85 | -1.5% | -35.8% | HK$55.8b | HK$66.21 | PS8.2x | E116.2% | n/a | ||
| 1801Innovent Biologics | HK$36.50 | 2.0% | -50.2% | HK$54.0b | HK$48.75 | PS10.8x | E57.8% | n/a | ||
| 2696Shanghai Henlius Biotech | HK$14.92 | -0.5% | -53.2% | HK$8.1b | HK$26.71 | PS4.1x | E83.7% | n/a | ||
| 6826Shanghai Haohai Biological Technology | HK$31.90 | 2.6% | -58.2% | HK$15.1b | HK$69.23 | PE15x | E20.6% | 2.6% | ||
| 570China Traditional Chinese Medicine Holdings | HK$3.20 | -1.8% | -24.2% | HK$16.1b | HK$4.74 | PE7.2x | E7.3% | 4.3% | ||
| 6622Zhaoke Ophthalmology | HK$3.10 | 0% | -61.0% | HK$1.7b | HK$12.81 | PB0.6x | E68.3% | n/a | ||
| 1952Everest Medicines | HK$16.34 | -1.6% | -74.5% | HK$4.8b | HK$41.00 | PS78055.6x | E33.6% | n/a | ||
| 6185CanSino Biologics | HK$64.75 | 0.08% | -78.2% | HK$30.8b | HK$173.79 | PE6.7x | E11.2% | 1.4% | ||
| 15303SBio | HK$5.31 | 1.1% | -28.6% | HK$12.9b | HK$8.18 | PE6.7x | E6.6% | 3.7% | ||
| 1666Tong Ren Tang Technologies | HK$5.10 | -2.5% | -12.1% | HK$6.6b | HK$7.69 | PE11.1x | E6.4% | 3.6% | ||
| 1643Modern Chinese Medicine Group | HK$0.44 | 3.5% | -43.6% | HK$276.0m | n/a | PE2.8x | n/a | 3.6% |
Page 1 of 1